Growth Metrics

Humana (HUM) Cash & Current Investments (2016 - 2025)

Humana has reported Cash & Current Investments over the past 17 years, most recently at $19.9 billion for Q4 2025.

  • Quarterly results put Cash & Current Investments at $19.9 billion for Q4 2025, down 2.6% from a year ago — trailing twelve months through Dec 2025 was $19.9 billion (down 2.6% YoY), and the annual figure for FY2025 was $19.9 billion, down 2.6%.
  • Cash & Current Investments for Q4 2025 was $19.9 billion at Humana, down from $22.1 billion in the prior quarter.
  • Over the last five years, Cash & Current Investments for HUM hit a ceiling of $31.5 billion in Q2 2023 and a floor of $16.6 billion in Q4 2021.
  • Median Cash & Current Investments over the past 5 years was $21.5 billion (2023), compared with a mean of $21.9 billion.
  • Biggest five-year swings in Cash & Current Investments: skyrocketed 72.98% in 2023 and later dropped 27.14% in 2024.
  • Humana's Cash & Current Investments stood at $16.6 billion in 2021, then grew by 14.2% to $18.9 billion in 2022, then grew by 12.55% to $21.3 billion in 2023, then decreased by 4.15% to $20.4 billion in 2024, then dropped by 2.6% to $19.9 billion in 2025.
  • The last three reported values for Cash & Current Investments were $19.9 billion (Q4 2025), $22.1 billion (Q3 2025), and $21.7 billion (Q2 2025) per Business Quant data.